DE2508218A1 - 20-hydroxymethylprostadiensaeurederivate - Google Patents

20-hydroxymethylprostadiensaeurederivate

Info

Publication number
DE2508218A1
DE2508218A1 DE19752508218 DE2508218A DE2508218A1 DE 2508218 A1 DE2508218 A1 DE 2508218A1 DE 19752508218 DE19752508218 DE 19752508218 DE 2508218 A DE2508218 A DE 2508218A DE 2508218 A1 DE2508218 A1 DE 2508218A1
Authority
DE
Germany
Prior art keywords
mixture
trans
acid
tetrahydropyran
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19752508218
Other languages
German (de)
English (en)
Inventor
Osamu Hasegawa
Noriyoshi Inukai
Yoshio Ishii
Hidenori Iwamoto
Masuo Murakami
Toshinari Tamura
Isao Yanagisawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2397174A external-priority patent/JPS50116453A/ja
Priority claimed from JP11106174A external-priority patent/JPS5139648A/ja
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Publication of DE2508218A1 publication Critical patent/DE2508218A1/de
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19752508218 1974-02-28 1975-02-26 20-hydroxymethylprostadiensaeurederivate Pending DE2508218A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2397174A JPS50116453A (enExample) 1974-02-28 1974-02-28
JP11106174A JPS5139648A (en) 1974-09-27 1974-09-27 Shinkina 166 arukiru 200 hidorokishimechirupurosutajensanjudotai no seiho

Publications (1)

Publication Number Publication Date
DE2508218A1 true DE2508218A1 (de) 1975-09-25

Family

ID=26361422

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752508218 Pending DE2508218A1 (de) 1974-02-28 1975-02-26 20-hydroxymethylprostadiensaeurederivate

Country Status (4)

Country Link
DE (1) DE2508218A1 (enExample)
ES (1) ES435208A1 (enExample)
FR (1) FR2262516A1 (enExample)
GB (1) GB1483316A (enExample)

Also Published As

Publication number Publication date
ES435208A1 (es) 1977-05-01
FR2262516A1 (enExample) 1975-09-26
GB1483316A (en) 1977-08-17

Similar Documents

Publication Publication Date Title
CH632245A5 (en) Process for preparing novel prostaglandin derivatives possessing a 9-deoxy-6,9-epoxy functionality
DE2734791C2 (enExample)
CH636096A5 (de) Bicyclische prostaglandine, verfahren zu ihrer herstellung und pharmazeutische praeparate.
DE2365035C2 (de) trans-Δ↑2↑-Prostaglandine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Mittel
DE2840032C2 (de) Prostaglandin-Analoge, Verfahren zu ihrer Herstellung, sowie diese enthaltende Arzneimittel
DE2409460A1 (de) Prostaglandinverbindungen und verfahren zu ihrer herstellung
DE2416193C2 (de) Prostaglandin-Analoge, Verfahren zu ihrer Herstellung sowie ihre Verwendung als cytoprotektives Mittel
EP0147461B1 (de) 11-halogen-prostanderivate, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel
DE2505519A1 (de) Prostaglandinanaloge, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2627673A1 (de) Prostaglandinartige 1,15-lactone sowie verfahren zu deren herstellung
DE2515770C2 (de) Prostaglandinanaloge, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2850885A1 (de) Bicyclische prostaglandine, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische und veterinaermedizinische mittel
DE2910474C2 (enExample)
CH636353A5 (de) Enolaether und verfahren zu deren herstellung.
DE2535343C2 (de) 2-(6'-Carboxy-n-hexyl)-3-n-hexyl-cyclopentanole und -derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2739277A1 (de) 11-deoxy-11-oxaprostaglandinverbindungen
DE2825440C2 (de) Prostaglandin-Analoge, Verfahren zu ihrer Herstellung, sowie diese enthaltende pharmazeutische Zusammensetzungen
CH640847A5 (en) Process for preparing analogues of 5,6-dihydroprostacyclin
DE2440919A1 (de) Prostaglandinanaloge, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
EP0013955A1 (de) Neue Analoga von Prostacyclin, deren Zwischenprodukte, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
DE2640692C3 (de) Optisch aktive 5- (2-Carboxythiophen5-yl)-16phenoxy- a -tetranor- w tetranor-prostaglandine
DE2542686A1 (de) 2a,2b-dihomo-15-methyl- und -15- aethyl-pgf-und pge-verbindungen und verfahren zu deren herstellung
CH624100A5 (enExample)
CH632492A5 (en) Process for preparing novel prostanoic acid derivatives
CH632743A5 (de) Verfahren zur herstellung neuer prostaglandin-analoga mit einer 4,5-doppelbindung.

Legal Events

Date Code Title Description
OHJ Non-payment of the annual fee